Rybelsus 14 mg Semaglutide Tablets
Rybelsus 14 mg contains the active ingredient Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise.How It WorksStimulates the pancreas to release insulin in response to elevated blood sugar levels.Reduces the amount of glucose produced and released by the liver.Slows gastric emptyi
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Rybelsus 14 mg contains the active ingredient Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise.
How It Works
- Stimulates the pancreas to release insulin in response to elevated blood sugar levels.
- Reduces the amount of glucose produced and released by the liver.
- Slows gastric emptying after meals to assist in blood sugar management.
Administration Guidelines
Take Rybelsus 14 mg exactly as directed by your healthcare professional. The tablet should be swallowed whole with a glass of water on an empty stomach upon waking. Do not chew, crush, or split the tablet. Wait at least 30 minutes after taking the tablet before consuming your first food, beverage, or other oral medications of the day.
Storage
Store refrigerated between 2°C and 8°C. Keep safely out of reach of children and pets.
| Brand | Rybelsus |
| Manufacturer | Novo Nordisk |
| Active Ingredient | Semaglutide |
| Drug Class | Glucagon-like peptide-1 (GLP-1) Receptor Agonist |
| Dosage Strength | 14 mg |
| Dosage Form | Tablet |
| Indication | Type 2 Diabetes |
| Packaging Format | 10 Tablets per strip |
| Brand | Rybelsus |
|---|








Reviews
There are no reviews yet.